# q01 rev 1 - blind solver B (fresh blind-solver, packet solver-2), 2026-10-06

Raw return as received:

answer: Flat. The guidance in effect in April 2026 projected flat (about 0%) fiscal 2026 adjusted operating income growth for "Other", against a fiscal 2025 actual of $352M. This was the guidance issued on February 4, 2026.

confidence: high

path:
1. **When the divestiture happened.** D05 (Q3 FY2026 release, Aug 5, 2026), line 81, says the U.S. Consulting Services business "was divested in April 2026". The footnotes at lines 269 and 393 repeat this, and line 95 says "the April 2026 divestiture of U.S. Consulting Services". No document gives a more exact date.
2. **Which group included it.** D01, line 81: "other businesses for which the Company is exploring strategic alternatives have been grouped together in Other. These businesses include MWI Animal Health, Profarma, U.S. Consulting Services, and certain components of PharmaLex." D06, line 121, adds that "Other, which is not considered a reportable segment" includes "U.S. Consulting Services". So the group is "Other".
3. **Guidance dates.** The documents date the guidance releases as follows:
   - D06: Nov 5, 2025
   - D01: Feb 4, 2026
   - D03: May 6, 2026
   - D05: Aug 5, 2026

   All of April 2026 falls after D01 and before D03, so D01's guidance was the one in effect.
4. **What D01's guidance said.** D01, line 114, "Other" adjusted operating income row: "|Other(2)|Flat|$352M|". The original docs file shows the same row at line 115. D01, line 103, explains the change: "improved results in Other as certain depreciable assets have been fully impaired as of December 31, 2025."
5. **D01 was still in effect until May 6.** D03, line 17: "Adjusted diluted EPS guidance has been raised from the previous range of $17.45 to $17.75". That is the same range D01 reaffirmed. D03, line 112, says the May update included "updated operating income expectations in Other as a result of MWI now being accounted for as 'held for sale'."
6. **How "Other" guidance changed over time (for exclusion):**
   - D06 (Nov 2025), line 138: "1% to 4% decline"
   - D01 (Feb 2026): "Flat"
   - D03 (May 2026), line 123: "High-single digit growth"
   - D05 (Aug 2026), line 118: "~10% growth"

   No arithmetic is needed. "Flat" against $352M means about 0% growth.

minimal_documents: D01 and D05. D01 is the only source of "Flat" and D05 is the only source of the April 2026 date. D03 is optional: it confirms the next update came on May 6, after April. I found no replacement for D01 or D05.

readings:
- **First guidance issued after the divestiture (D03, May 6, 2026):** "High-single digit growth". This is not the guidance that was current in April.
- **Guidance in the release that first disclosed the divestiture (D05, Aug 5, 2026):** "~10% growth".
- **Original FY2026 guidance (D06, Nov 5, 2025):** "1% to 4% decline". The February 2026 update replaced it.
- **Total-company figure instead of "Other":** D01 line 111 gives "11.5% to 13.5% growth". That doesn't fit "the group of businesses that included it".

gaps:
- No document gives the exact day in April 2026.
- The packet has only earnings releases. It can't rule out a guidance change made elsewhere between Feb 4 and Apr 30, 2026, such as at the March 2026 investor conferences listed in D01. D03's "previous range of $17.45 to $17.75" suggests there wasn't one.
- D05's "previous range of $17.70 to $17.90" shows a guidance update outside the packet happened between May 6 and Aug 5, 2026. That is after April, so it doesn't affect the answer.
- The bold type that marks updated guidance figures is lost in the text. The documents are .txt files, with no PDFs or layout files to check.
- Coverage:
  - Read in full: D01 lines 1–159, D03 lines 1–140, D05 lines 1–135 and 262–273, D06 lines 1–160.
  - Searched only: the rest of those files, plus D02 and D04, which have no "2026" matches.
  - Not read: question.txt and anything outside text/ and docs/.

contaminated: no

Files used (in D:\Dev\Docket\tasks\aq-01322\runs\q01-r1-v2-0c4ada79857fe6002f3e54c31fc4c9ba16909a3d678a0fee82bef0a049662c74\solver-2):
- text\D01.txt
- text\D03.txt
- text\D05.txt
- text\D06.txt
- docs\cencora-inc-q1-fy2026-earnings-release-form-8-k-item-2-02-ex-99-1-filed-2026-02-04.txt
